As of 2024-12-12, the Relative Valuation of AlzeCure Pharma AB (ALZCUR.ST) is - SEK. This relative valuation is based on P/E multiples. With the latest stock price at 1.19 SEK, the upside of AlzeCure Pharma AB based on Relative Valuation is -.
The range of the Relative Valuation is - SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-12-10 | -2.95 |
| 2024-12-09 | -2.94 |
| 2024-12-06 | -2.99 |
| 2024-12-05 | -2.89 |
| 2024-12-04 | -2.77 |
| 2024-12-03 | -2.72 |
| 2024-12-02 | -2.84 |
| 2024-11-29 | -2.93 |
| 2024-11-28 | -2.55 |
| 2024-11-27 | -2.51 |
| 2024-11-26 | -2.65 |
| 2024-11-25 | -2.81 |
| 2024-11-22 | -2.58 |
| 2024-11-21 | -2.47 |
| 2024-11-20 | -2.77 |
| 2024-11-19 | -2.81 |
| 2024-11-18 | -2.86 |
| 2024-11-15 | -3.11 |
| 2024-11-14 | -3.40 |
| 2024-11-13 | -3.82 |
| 2024-11-12 | -4.02 |
| 2024-11-11 | -3.99 |
| 2024-11-08 | -3.77 |
| 2024-11-07 | -3.88 |
| 2024-11-06 | -3.82 |
| 2024-11-05 | -4.09 |
| 2024-11-04 | -4.26 |
| 2024-11-01 | -4.23 |
| 2024-10-31 | -4.34 |
| 2024-10-30 | -4.27 |
| 2024-10-29 | -4.38 |
| 2024-10-28 | -4.43 |
| 2024-10-25 | -4.41 |
| 2024-10-24 | -4.48 |
| 2024-10-23 | -4.39 |
| 2024-10-22 | -4.53 |
| 2024-10-21 | -4.53 |
| 2024-10-18 | -4.33 |
| 2024-10-17 | -4.33 |
| 2024-10-16 | -4.36 |
| 2024-10-15 | -4.32 |
| 2024-10-14 | -4.34 |
| 2024-10-11 | -4.44 |
| 2024-10-10 | -4.70 |
| 2024-10-09 | -4.55 |
| 2024-10-08 | -4.55 |
| 2024-10-07 | -4.52 |
| 2024-10-04 | -4.68 |
| 2024-10-03 | -4.55 |
| 2024-10-02 | -4.64 |